Medical pioneer Gilead Sciences has seen its stock etch out new 52-week highs as the broader market pulled back sharply in recent weeks. Gilead has joined Johnson & Johnson, and a cluster of …
Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson
view original post